Editorial: human genome information.
作者信息
Ho Rodney J Y
机构信息
Department of Pharmaceutics, University of Washington, Seattle, Washington 98195-7610.
出版信息
J Pharm Sci. 2011 Oct;100(10):4045-6. doi: 10.1002/jps.22713. Epub 2011 Jul 20.
Abstract
摘要
相似文献
1
Editorial: human genome information.社论：人类基因组信息
J Pharm Sci. 2011 Oct;100(10):4045-6. doi: 10.1002/jps.22713. Epub 2011 Jul 20.
2
Lead PK commentary: predicting human pharmacokinetics.铅药代动力学评论：预测人体药代动力学。
J Pharm Sci. 2011 Oct;100(10):4047-9. doi: 10.1002/jps.22637. Epub 2011 May 31.
3
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.制药研究和制造商协会（PHRMA）与美国疾病控制与预防中心（CPCDC）关于人体药代动力学预测模型的倡议，第5部分：使用基于生理学的药代动力学建模方法预测人体血浆浓度-时间曲线
J Pharm Sci. 2011 Oct;100(10):4127-57. doi: 10.1002/jps.22550. Epub 2011 May 3.
4
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.制药研究和制造商协会（PhRMA）与中国疾病预防控制中心（CPCDC）关于人类药代动力学预测模型的倡议，第4部分：使用和岛方法根据体内临床前数据预测人体血浆浓度-时间曲线
J Pharm Sci. 2011 Oct;100(10):4111-26. doi: 10.1002/jps.22551. Epub 2011 Apr 7.
5
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.制药研究和制造商协会（PhRMA）与美国疾病控制与预防中心（CPCDC）关于人体药代动力学预测模型的倡议，第3部分：人体清除率预测方法的比较评估
J Pharm Sci. 2011 Oct;100(10):4090-110. doi: 10.1002/jps.22552. Epub 2011 May 3.
6
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.制药研究与制造商协会（PhRMA）关于人类药代动力学预测模型的CPCDC计划，第1部分：目标、PhRMA数据集的特性以及与文献数据集的比较。
J Pharm Sci. 2011 Oct;100(10):4050-73. doi: 10.1002/jps.22554. Epub 2011 Apr 26.
7
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.制药研究和制造商协会（PhRMA）关于人体药代动力学预测模型的合作项目，第2部分：人体分布容积预测方法的比较评估
J Pharm Sci. 2011 Oct;100(10):4074-89. doi: 10.1002/jps.22553. Epub 2011 Mar 30.
8
The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.IGNITE药物遗传学工作组：在现实环境中通过药物遗传学实施建立证据的契机。
Clin Transl Sci. 2017 May;10(3):143-146. doi: 10.1111/cts.12456. Epub 2017 Mar 14.
9
[Genomic medicine and infectious diseases].[基因组医学与传染病]
Praxis (Bern 1994). 2014 May 7;103(10):587-90. doi: 10.1024/1661-8157/a001658.
10
Connecting the pharmacogenetics and personalised medicine community.连接药物遗传学与个性化医疗领域。
Drug Discov Today. 2018 Aug;23(8):1456-1457. doi: 10.1016/j.drudis.2018.06.008. Epub 2018 Jun 13.
Zotero 插件